| 南亞技術學院 |
1984-11 |
Henry James's International Theme In The Portrait of a Lady
|
李麗芳 |
| 淡江大學 |
2006 |
Henry James's The Portrait of a Lady on screen : Jane Campion's feminist adaptation
|
江怡菁; Chiang, Yi-ching |
| 國立臺灣大學 |
1951 |
Henry Jemes as a Novelist
|
黃炎生 |
| 臺大學術典藏 |
2022-03-21T08:53:22Z |
Henry VI in the Exclusion Crisis: Shakespeare Adaptation and the Poetics of Fear
|
Yi-Hsin Hsu |
| 中國文化大學 |
1971-09 |
Henry W. Wells
|
胡品清 |
| 國立政治大學 |
2001 |
Henry Willobie
|
林質心; Lin, Chih-hsin |
| 臺大學術典藏 |
2020-02-25T06:12:22Z |
Henry's constants and mass transfer coefficients of halogenated organic pollutants in an air stripping packed column
|
Chiang, P.-C.; Hung, C.-H.; Mar, J.C.; Chang, E.E.; PEN-CHI CHIANG |
| 臺大學術典藏 |
2020-02-25T06:12:27Z |
Henry's constants and mass transfer coefficients of halogenated organic pollutants in an air stripping packed column
|
Chiang, P. C.; Hung, C. H.; Mar, J. C.; Chang, E. E.; PEN-CHI CHIANG |
| 臺北醫學大學 |
1998 |
Henry's constants and mass transfer coefficients of halogenated organic pollutants in an air stripping packed column.
|
張怡怡; Chiang PC; Hung CH; Mar JC and Chang EE |
| 臺大學術典藏 |
2018-09-10T04:08:38Z |
Henry's law constant of organic compounds in water from a group contribution model with multipole corrections
|
Lin, S.-T.; S; ler, S.I.; SHIANG-TAI LIN |
| 南華大學 |
2006 |
Henry's Law Constant Variations of Volatile Organic Compounds in Wastewater and Activated Sludge
|
林俊宏;Jun-Hong Lin, Ming-Shean Chou |
| 臺北醫學大學 |
2010 |
HEP Inhibits Lipopolysaccharide-Induced Osteoclastogenesis and Cytokine Synthesis
|
TP, Hsieh;JS, Sun;SY, Sheu |
| 臺北醫學大學 |
2010 |
HEP Inhibits Lipopolysaccharide-Induced Osteoclastogenesis and Cytokine Synthesis
|
Hsieh, TP;Sun, JS;Sheu, SY |
| 東海大學 |
2009-12 |
HEp-2 Cell Classification in Indirect Immunofluorescence Images
|
黃育仁; T. Y. Hsieh, Y. C. Huang, C. W. Chung and Y. L. Huang |
| 東海大學 |
2009-12-08 |
HEp-2 cell classification in indirect immunofluorescence images
|
Hsieh, T.-Y.a , Huang, Y.-C.b , Chung, C.-W.b, Huang, Y.-L.b |
| 東海大學 |
2009-12-08 |
HEp-2 cell classification in indirect immunofluorescence images
|
Hsieh, T.-Y.a , Huang, Y.-C.b , Chung, C.-W.b, Huang, Y.-L.b |
| 東海大學 |
2012-03-19 |
HEp-2 cell images classification based on textural and statistic features using self-organizing map
|
Huang, Y.-C.a , Hsieh, T.-Y.b, Chang, C.-Y.a, Cheng, W.-T.a, Lin, Y.-C.a, Huang, Y.-L. |
| 東海大學 |
2012-03-19 |
HEp-2 cell images classification based on textural and statistic features using self-organizing map
|
Huang, Y.-C.a , Hsieh, T.-Y.b, Chang, C.-Y.a, Cheng, W.-T.a, Lin, Y.-C.a, Huang, Y.-L. |
| 國立成功大學 |
2002-07-29 |
Hepa-1 小鼠細胞蛋白質體如何受2 3 7 8-四氯戴奧辛影響
|
洪千雯; Hung, Chien-Wen |
| 國立臺灣大學 |
2015 |
Heparan Sulfate Modulates Neutrophil and Endothelial Function in Antibacterial Innate Immunity
|
Xu, Ding; Olson, Joshua; Cole, Jason N.; van Wijk, Xander M.; Brinkmann, Volker; Zychlinsky, Arturo; Nizet, Victor; Esko, Jeffrey D.; Chang, Yung-Chi; 張永祺 |
| 臺大學術典藏 |
2000 |
Heparan sulfate proteoglycans as extracellular docking molecules for matrilysin (matrix metalloproteinase 7)
|
Wei-Hsuan Yu;Woessner Jr. J.F.; WEI-HSUAN YU; Woessner Jr. J.F. |
| 國立成功大學 |
2009-05 |
Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: A randomized phase II trial for safety and optimal dosage
|
Liu, Chun-Jen; Lee, Po-Huang; Lin, Deng-Yn; Wu, Cheng-Chung; Jeng, Long-Bin; Lin, Pin-Wen; Mok, King-Tong; Lee, Wei-Chen; Yeh, Hong-Zen; Ho, Ming-Chih; Yang, Sheng-Shun; Lee, Ching-Chih; Yu, Ming-Chin; Hu, Rey-Heng; Peng, Cheng-Yuan; Lai, Kuan-Lang; Chang, Stanley Shi-Chung; Chen, Pei-Jer |
| 臺大學術典藏 |
2020-11-19T03:19:55Z |
Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: A randomized phase II trial for safety and optimal dosage
|
Liu C.-J.; PO-HUANG LEE; Lin D.-Y.; Wu C.-C.; Jeng L.-B.; Lin P.-W.; Mok K.-T.; Lee W.-C.; Yeh H.-Z.; Ho M.-C.; Yang S.-S.; Lee C.-C.; Yu M.-C.; Hu R.-H.; Peng C.-Y.; Lai K.-L.; Chang S.S.-C.; Chen P.-J. |
| 臺大學術典藏 |
2021-07-03T03:34:53Z |
Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: A randomized phase II trial for safety and optimal dosage
|
Liu C.-J.; Lee P.-H.; Lin D.-Y.; Wu C.-C.; Jeng L.-B.; Lin P.-W.; Mok K.-T.; Lee W.-C.; Yeh H.-Z.; Ho M.-C.; Yang S.-S.; Lee C.-C.; Yu M.-C.; Hu R.-H.; Peng C.-Y.; Lai K.-L.; Chang S.S.-C.; PEI-JER CHEN |
| 臺大學術典藏 |
2022-01-24T09:32:03Z |
Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: A randomized phase II trial for safety and optimal dosage
|
CHUN-JEN LIU; Lee P.-H.; Lin D.-Y.; Wu C.-C.; Jeng L.-B.; Lin P.-W.; Mok K.-T.; Lee W.-C.; Yeh H.-Z.; Ho M.-C.; Yang S.-S.; Lee C.-C.; Yu M.-C.; Hu R.-H.; Peng C.-Y.; Lai K.-L.; Chang S.S.-C.; Chen P.-J. |
